Prediction of coronary artery disease and cardiac events using electrocardiographic changes during hemodialysis

Citation
S. Nakamura et al., Prediction of coronary artery disease and cardiac events using electrocardiographic changes during hemodialysis, AM J KIDNEY, 36(3), 2000, pp. 592-599
Citations number
25
Categorie Soggetti
Urology & Nephrology
Journal title
AMERICAN JOURNAL OF KIDNEY DISEASES
ISSN journal
02726386 → ACNP
Volume
36
Issue
3
Year of publication
2000
Pages
592 - 599
Database
ISI
SICI code
0272-6386(200009)36:3<592:POCADA>2.0.ZU;2-S
Abstract
Hemodialysis(HD) patients have a high rate of cardiac morbidity and mortali ty. Both symptomatic and silent ischemic heart disease may occur frequently during HD because HD simultaneously reduces coronary artery oxygen deliver y while increasing myocardial oxygen demand. The purpose of the present stu dy Is to prospectively evaluate the usefulness of a significant ST depressi on induced by HD for the diagnosis of coronary artery disease (CAD) and as the predictor of subsequent cardiac events in HD patients. Sixty-one patien ts undergoing chronic HD (50 men, 11 women; mean age, 61 years) admitted fo r such cardiac symptoms as chest pain (n = 43), arrhythmia (n = 5), or hear t failure (n = 13) were studied; 38 patients had CAD by coronary angiograph y. Electrocardiograms performed during HD showed an additional depression ( greater than or equal to 1.0 mV) of the ST segment in 18 patients (positive -ST group), but not in 43 patients (negative-ST group). The incidence of CA D was significantly greater in the former (100%) than in the latter group ( 46%). A prospective follow-up was performed for 21 +/- 2 months, and cardia c events occurred in all positive-ST group patients and in 21 negative-ST g roup patients. Event-free survival was poorer in the positive-ST group (P < 0.0001). A Cox proportional hazards model identified the significant ST de pression as an independent risk factor for cardiac morbidity (P < 0.05), bu t not for ail-cause mortality. ST depression during HD is useful to diagnos e CAD in symptomatic patients and is considered an important prognosticator of subsequent cardiac events. (C) 2000 by the National Kidney Foundation, Inc.